Medical Research
(H12)
IRS Verified
DX Registered
990 on File
FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS
Financial strength (30%)
73/100
Reliability (20%)
50/100
Effectiveness (25%)
81/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$5.4M
Total Revenue
$10.4M
Total Expenses
$40.2M
Net Assets
11
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
88.8%
Fundraising Efficiency
123.6%
Operating Reserve
46.43x
Liability-to-Asset
10.5%
Revenue Diversification
69.1%
Executive Compensation
$764K
Compared with Peers
FY 2024
Compared with 98 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
88.8% | 82.0% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
7.3% | 12.7% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
3.8% | 0.7% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
123.6% | 693.4% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
46.4 mo | 14.5 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
10.5% | 21.3% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
69.1% | 90.8% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-17.4% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-55.3% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-92.9% | -1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $5.4M | $10.4M | $40.2M | 88.8% | 11 |
| 2023 | $6.5M | $23.2M | $39.8M | 94.9% | 9 |
| 2022 | $52.5M | $8.9M | $55.8M | 89.5% | 8 |
| 2021 | $4.0M | $5.8M | N/A | — | 6 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.